Concepedia

Publication | Open Access

Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC

DOIFull Paper Access

42

Citations

32

References

2017

Year

Leona L. Pott, Sascha Hagemann, Henning Reis, Kristina Lorenz, Thilo Bracht, Thomas Herold, Boris V. Skryabin, Dominik A. Megger, Julia Kälsch, Frank Weber,
Oncotarget

Abstract

eEF2 and phosphorylated eEF2 are prognostic markers for survival of hepatocellular carcinoma patients and the regulating eEF2 kinase is a potential drug target for tumor therapy.

References

YearCitations

Page 1